Literature DB >> 24895396

Breathless after bypass.

Simon G Pearse1, Constantinos Missouris1, Muhammad Ali Qureshi1.   

Abstract

A 65-year-old normotensive, non-athletic man presented to the cardiology clinic with exertional dyspnoea and chest discomfort. Echocardiography revealed mild left ventricular hypertrophy with good systolic function but with regional wall motion abnormalities suggesting ischaemia. Coronary angiography showed significant three-vessel disease. He underwent coronary artery bypass surgery, which was complicated by recurrent pericardial and pleural effusions, requiring a pericardial window procedure. Over the following year he became increasingly oedematous and breathless. On ECG the complexes were low voltage with impaired R wave progression and atrial fibrillation. Echocardiography revealed progression of the left ventricular hypertrophy (LVH) with a bright myocardium and restrictive filling pattern. MRI scanning confirmed the diagnosis of cardiac amyloidosis. He was referred for transplant but was considered unsuitable due to extensive mediastinal scarring. This case demonstrates the importance of a high index of suspicion for amyloidosis, especially in patients with unexplained LVH. Cardiac MRI or biopsy may expedite the diagnosis. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24895396      PMCID: PMC4054519          DOI: 10.1136/bcr-2014-204468

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Combined heart and liver transplantation for familial amyloidotic polyneuropathy.

Authors:  Giorgio Arpesella; Bruno Chiappini; Giuseppe Marinelli; Piero Maria Mikus; Franco Dozza; Angelo Pierangeli; Carlo Magelli; Francesco Salvi; Ornella Leone
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

2.  Outcome of heart transplantation in patients with amyloid cardiomyopathy.

Authors:  Jacques Kpodonu; Malek G Massad; Amitra Caines; Alexander S Geha
Journal:  J Heart Lung Transplant       Date:  2005-11       Impact factor: 10.247

3.  Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study.

Authors:  Maarit Tanskanen; Terhi Peuralinna; Tuomo Polvikoski; Irma-Leena Notkola; Raimo Sulkava; John Hardy; Andrew Singleton; Sari Kiuru-Enari; Anders Paetau; Pentti J Tienari; Liisa Myllykangas
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

4.  Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.

Authors:  Angela Dispenzieri; Morie A Gertz; Robert A Kyle; Martha Q Lacy; Mary F Burritt; Terry M Therneau; Philip R Greipp; Thomas E Witzig; John A Lust; S Vincent Rajkumar; Rafael Fonseca; Steven R Zeldenrust; Christopher G A McGregor; Allan S Jaffe
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

Review 5.  Amyloid heart disease.

Authors:  Rodney H Falk; Simon W Dubrey
Journal:  Prog Cardiovasc Dis       Date:  2010 Jan-Feb       Impact factor: 8.194

  5 in total
  1 in total

1.  Left ventricular global longitudinal strain in identifying subclinical myocardial dysfunction among patients hospitalized with COVID-19.

Authors:  Hezzy Shmueli; Maulin Shah; Joseph E Ebinger; Long-Co Nguyen; Fernando Chernomordik; Nir Flint; Patrick Botting; Robert J Siegel
Journal:  Int J Cardiol Heart Vasc       Date:  2021-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.